AMPK, an active player in the control of metabolism;L'AMPK: Une enzyme au coeur de l'homéostasie énergé tique

Journal de la Societe de Biologie

Volumn 200, Issue 1, 2006, Pages 99-105

  Daval, Marie ^a   Ferré, Pascal ^a   Foufelle, Fabienne ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845600813     PISSN: 12950661     EISSN: None     Source Type: Journal    
DOI: 10.1051/jbio:2006013     Document Type: Review

References (44)

1. Andersson U., Filipsson K., Abbott C. R., Woods A., Smith K., Bloom S. R., Carling D. & Small C. J., AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem., 2004, 279, 12005-12008.
2. Banerjee R. R., Rangwala S. M., Shapiro J. S., Rich A. S., Rhoades B., Qi Y., Wang J., Rajala M. W., Pocai A., Scherer P. E. et al., Regulation of fasted blood glucose by resistin. Science, 2004, 303, 1195-1198.
3. Berg A. H., Combs T. P. & Scherer P. E., ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab., 2002, 13, 84-89.
4. Carling D., The AMP-activated protein kinase cascade - a unifying system for energy control. Trends Biochem. Sci., 2004, 29, 18-24.
5. Carlson C. A. & Kim K. H., Regulation of hepatic acetyl coenzyme A carboxylase by phosphorylation and dephosphorylation. J. Biol. Chem., 1973, 248, 378-380.
6. Cheung P. C., Salt I. P., Davies S. P., Hardie D. G. & Carling D., Characterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding. Biochem. J., 2000, 346, 659-669.
7. Clarke P. R. & Hardie D. G., Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver. EMBO J., 1990, 9, 2439-2446.
8. Daval M., Diot-Dupuy F., Bazin R., Hainault I., Viollet B., Vaulont S., Hajduch E., Ferre P. & Foufelle F., Anti-lipolytic action of AMP-activated protein kinase in rodent adipocytes. J. Biol. Chem., 2005, 280, 25250-25257.
9. Fryer L. G., Foufelle F., Barnes K., Baldwin S. A., Woods A. & Carling D., Characterization of the role of the AMP-activated protein kinase in the stimulation of glucose transport in skeletal muscle cells. Biochem. J., 2002a, 363, 167-174.
10. Fryer L. G., Hajduch E., Rencurel F., Salt I. P., Hundal H. S., Hardie D. G. & Carling D., Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase. Diabetes, 2000, 49, 1978-1985.
11. Fryer L. G., Parbu-Patel A. & Carling D., The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem., 2002b, 277, 25226-25232.
12. Haque M. S., Minokoshi Y., Hamai M., Iwai M., Horiuchi M. & Shimazu T., Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats. Diabetes, 1999, 48, 1706-1712.
13. Hardie D. G., The AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology, 2003, 144, 5179-5183.
14. Hawley S. A., Boudeau J., Reid J. L., Mustard K. J., Udd L., Makela T. P., Alessi D. R. & Hardie D. G., Complexes between the LKB1 tumor suppressor, STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade. J. Biol., 2003, 2, 28.
15. Hawley S. A., Pan D. A., Mustard K. J., Ross L., Bain J., Edelman A. M., Frenguelli B. G. & Hardie D.G., Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase. Cell. Metab., 2005, 2, 9-19.
16. 2+/calmodulin- dependent protein kinase kinase. J. Biomed. Sci., 1998, 5, 141-149.
17. 2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem., 2005, 280, 29060-29066.
18. Kahn B. B., Alquier T., Carling D. & Hardie D. G., AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell. Metab., 2005, 1, 15-25.
19. Kawaguchi T., Osatomi K., Yamashita H., Kabashima T. & Uyeda K., Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase. J. Biol. Chem., 2002, 277, 3829-3835.
20. Kim M. S. & Lee K. U., Role of hypothalamic 5′-AMP-activated protein kinase in the regulation of food intake and energy homeostasis. J. Mol. Med., 2005, 83, 514-520.
21. Lochhead P. A., Salt I. P., Walker K. S., Hardie D. G. & Sutherland C., 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes, 2000, 49, 896-903.
22. Loftus T. M., Jaworsky D. E., Frehywot G. L., Townsend C. A., Ronnett G. V., Lane M. D. & Kuhajda F. P., Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science, 2000, 288, 2379-2381.
23. Marsin A. S., Bertrand L., Rider M. H., Deprez J., Beauloye C., Vincent M. F., Van den Berghe G., Carling D. & Hue L., Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr. Biol., 2000, 10, 1247-1255.
24. Mayerson A. B., Hundal R. S., Dufour S., Lebon V., Befroy D., Cline G. W., Enocksson S., Inzucchi S. E., Shulman G. I. & Petersen K. F., The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes, 2002, 51, 797-802.
25. Minokoshi Y., Alquier T., Furukawa N., Kim Y. B. Lee A., Xue B., Mu J., Foufelle F., Ferre P., Birnbaum M. J., Stuck B. J. & Kahn B. B., AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature, 2004, 428, 569-574.
26. Minokoshi Y., Kim Y. B., Peroni O. D., Fryer L. G., Muller C., Carling D. & Kahn B. B., Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature, 2002, 415, 339-343.
27. Musi N., Hirshman M. F., Nygren J., Svanfeldt M., Bavenholm P., Rooyackers O., Zhou G., Williamson J. M., Ljunqvist O., Efendic S. et al., Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes, 2002, 51, 2074-2081.
28. Olefsky J. M., Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists. J. Clin. Invest., 2000, 106, 467-472.
29. Park K. S., Ciaraldi T. P., Lindgren K., Abrams-Carter L., Mudaliar S., Nikoulina S. E., Tufari S. R., Veerkamp J. H., Vidal-Puig A. & Henry R. R., Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-γ. J. Clin. Endocrinol. Metab., 1998, 83, 2830-2835.
30. Patel L., Buckels A. C., Kinghorn I. J., Murdock P. R., Holbrook, J. D., Plumpton C., Macphee C. H. & Smith S. A., Resistin is expressed in human macrophages and directly regulated by PPARγ activators. Biochem. Biophys. Res. Commun., 2003, 300, 472-476.
31. rd, Bergeron R., Shulman G. I. & Young L. H., Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am. J. Physiol., 1999, 277, H643-H649.
32. Saha A. K., Avilucea P. R., Ye J. M., Assifi M. M., Kraegen E.W., & Ruderman N. B., Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo. Biochem. Biophys. Res. Commun., 2004, 314, 580-585.
33. Saha A. K., Laybutt D. R., Dean D., Vavvas, D., Sebokova, E., Ellis, B., Klimes, I., Kraegen E. W., Shafrir E., & Ruderman N. B., Cytosolic citrate and malonyl-CoA regulation in rat muscle in vivo. Am. J. Physiol., 1999, 276, E1030-E1037.
34. Shulman G. I., Cellular mechanisms of insulin resistance. J. Clin. Invest., 2000, 106, 171-176.
35. Steppan C. M., Bailey S. T., Bhat S., Brown E. J., Banerjee R. R., Wright C. M., Patel H. R., Ahima R. S. & Lazar M. A., The hormone resistin links obesity to diabetes. Nature, 2001, 409, 307-312.
36. Sullivan J. E., Brocklehurst K. J., Marley A. E., Carey F., Carling D. & Beri R. K., Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Lett., 1994, 353, 33-36.
37. 2+/calmodulin-dependent protein kinase cascade. Molecular cloning and expression of calcium/calmodulin-dependent protein kinase kinase. J. Biol. Chem., 1995, 270, 19320-19324.
38. Tsao T. S., Lodish H. F. & Fruebis J., ACRP30, a new hormone controlling fat and glucose metabolism. Eur. J. Pharmacol., 2002, 440, 213-221.
39. Winder W. W., Holmes B. F., Rubink D. S., Jensen E. B., Chen M. & Holloszy J. O., Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J. Appl. Physiol., 2000, 88, 2219-2226.
40. 2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells. Cell. Metab., 2005, 2, 21-33.
41. Woods A., Johnstone S. R., Dickerson K., Leiper F. C., Fryer L. G., Neumann D., Schlattner U., Wallimann T., Carlson M. & Carling D., LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol., 2003, 13, 2004-2008.
42. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K. et al., Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med., 2002, 8, 1288-1295.
43. Zang M., Zuccollo A., Hou X., Nagata D., Walsh K., Herscovitz H., Brecher P., Ruderman N. B. & Cohen R. A., AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J. Biol. Chem., 2004, 279, 47898-47905.
44. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M. F., Goodyear L. J. & Moller D. E., Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest., 2001, 108, 1167-1174.